Cite
HARVARD Citation
Fadlyana, E. et al. (2021). A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia. Vaccine. 39 (44), pp. 6520-6528. [Online].